Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity
{{output}}
The rapid and widespread clinical adoption of highly effective incretin-mimetic drugs (IMDs), particularly semaglutide and tirzepatide, for the treatment of obesity has outpaced the updating of clinical practice guidelines. Consequently, many patients may be a... ...
